SCHEMBL16196930

SCHEMBL16196930

C[C]=NOCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3562937 1.00
SCHEMBL1550093 1.00
SCHEMBL28821027 0.78
SCHEMBL5207974 0.78
SCHEMBL31181466 0.76
SCHEMBL6782850 0.75
SCHEMBL22283026 0.75
SCHEMBL6782847 0.75
SCHEMBL4407935 0.71
SCHEMBL4399559 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100556904-C 3- (dihydro (tetrahydro) isoquinolin-1-yl) quinoline compounds SANKYO AGRO CO LTD (JP) 2009-11-04 CN claimed
CN-1910172-A 3- (dihydro (tetrahydro) isoquinolin-1-yl) quinoline compounds SANKYO AGRO CO LTD (JP) 2007-02-07 CN claimed
CN-1071749-C Acylated 5-aminoisothiazoles with insecticidal properties, intermediate products and process for producing them BAYER AG (DE) 2001-09-26 CN claimed
CN-1225632-A Substituted N- (5-isothiazolyl) -thioamides BAYER AG (DE) 1999-08-11 CN claimed
CN-1202162-A Acylated 5-aminoisothiazoles with insecticidal properties, intermediate products and process for producing them BAYER AG (DE) 1998-12-16 CN claimed
US-20210315892-A1 THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, FIBROTIC DISEASES, AND CANCER DISEASES MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-10-14 US disclosed
EP-3560925-B1 NOVEL COMPOUND AND PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF MEIJI SEIKA PHARMA CO LTD (JP) 2021-06-02 EP disclosed
EP-3815687-A1 THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, FIBROTIC DISEASES, AND CANCER DISEASES Meiji Seika Pharma Co., Ltd. (JP) 2021-05-05 EP disclosed
US-10669283-B2 Compound and pharmacologically acceptable salt thereof MEIJI SEIKA PHARMA CO., LTD. (JP) 2020-06-02 US disclosed
EP-3560925-A1 NOVEL COMPOUND AND PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF Meiji Seika Pharma Co., Ltd. (JP) 2019-10-30 EP disclosed
US-20190322686-A1 NOVEL COMPOUND AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF MEIJI SEIKA PHARMA CO., LTD. (JP) 2019-10-24 US disclosed
CN-110352192-A Heterocyclic compound and harmful arthropod control agent containing same 住友化学株式会社 2019-10-18 CN disclosed
CN-105705017-A Co-crystal and method for producing same 日本曹达株式会社 2016-06-22 CN disclosed
CN-104302644-A Thiazolecarboxamide derivatives and methods of use thereof NIHON NOHYAKU CO LTD 2015-01-21 CN disclosed
WO-2014172871-A1 DIHYDROBENZOFURAN DERIVATIVES AS INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2014-10-30 WO disclosed
CN-100556904-C 3- (dihydro (tetrahydro) isoquinolin-1-yl) quinoline compounds SANKYO AGRO CO LTD (JP) 2009-11-04 CN disclosed
CN-1910172-A 3- (dihydro (tetrahydro) isoquinolin-1-yl) quinoline compounds SANKYO AGRO CO LTD (JP) 2007-02-07 CN disclosed
CN-1071749-C Acylated 5-aminoisothiazoles with insecticidal properties, intermediate products and process for producing them BAYER AG (DE) 2001-09-26 CN disclosed
CN-1225632-A Substituted N- (5-isothiazolyl) -thioamides BAYER AG (DE) 1999-08-11 CN disclosed
CN-1202162-A Acylated 5-aminoisothiazoles with insecticidal properties, intermediate products and process for producing them BAYER AG (DE) 1998-12-16 CN disclosed